Last reviewed · How we verify
The Effect of Insulin Detemir on Glucose Control in Ageing Subjects With Type 2 Diabetes. (3L)
This trial is conducted in Europe. The aim of the trial is to compare insulin detemir once daily to NPH insulin once daily as measured by blood sugar control in ageing subjects with type 2 diabetes naive to previous insulin therapy.
Details
| Lead sponsor | Novo Nordisk A/S |
|---|---|
| Phase | Phase 4 |
| Status | TERMINATED |
| Enrolment | 86 |
| Start date | 2007-07 |
| Completion | 2008-12 |
Conditions
- Diabetes
- Diabetes Mellitus, Type 2
Interventions
- insulin detemir
- insulin NPH
Primary outcomes
- Change in Glycosylated Haemoglobin (HbA1c) at Month 7 — week 0, month 7
Countries
France, United Kingdom